key: cord-0264391-orla242s
authors: Pagadala, M. S.; Jasuja, G. K.; Palnati, M.; Lynch, J.; Anglin, T.; Chang, N.; Deka, R.; Lee, K. M.; Agiri, F. Y.; Seibert, T. M.; Rose, B. S.; Carter, H.; Panizzon, M. S.; Hauger, R. L.
title: Discovery of Novel Trans-Ancestry and Ancestry-Specific Gene Loci for Total Testosterone in a Multi-Ancestral Analysis of Men in the Million Veteran Program
date: 2022-02-17
journal: nan
DOI: 10.1101/2022.02.16.21265846
sha: 4089f4f4f5960904cc846c82fb9e13655b7ecedc
doc_id: 264391
cord_uid: orla242s

Utilizing data from the Million Veteran Program (MVP), we investigated the genetic determinants underlying total testosterone levels via a multi-ancestral analysis of 124,593 individuals of European (n=88,385), African (n=25,235) and Hispanic (n=10,973) ancestry. We identified 46 trans-ancestry variants and 17 ancestry-specific variants, of which 14 trans-ancestry variants and 15 ancestry-specific variants are novel associations with testosterone. Results implicate genes regulating testosterone shared across ancestral groups, which include SHBG, JMJD1C, FXR2, SENP3, TNFSF12-TNFSF13 while also implicating genes such as MSN, DMD, VSIG4, CHEK2, TKTL1 that may underlie ancestry-group differences in testosterone regulation. We also linked testosterone variants on the X chromosome with differential risk of chronic kidney disease and hereditary hemolytic anemias in African and Hispanic ancestry groups, respectively. Lastly, we constructed a polygenic score from our 46 trans-ancestry variants and associated it with testicular dysfunction, hyperlipidemia, gout and prostate cancer with stronger prostate cancer associations in Hispanic and African ancestry groups compared to the European ancestry group. These findings provide insight into ancestry-specific androgen regulation and identify novel variants for disease risk stratification in patients.

Testosterone is an anabolic steroid synthesized by the testis which acts as the primary sex hormone in men 19 regulating sexual development during puberty and spermatogenesis and sexual function in adulthood [1] [2] [3] . Classical, 20 well-established roles of testosterone include stimulation of erythropoiesis, maintenance of muscular strength, 21 and maintenance of bone density mass; 4,5 however, research has discovered that testicular androgens, testosterone 22 and dihydrotestosterone have more extensive physiological actions with important roles in regulating 23 cardiovascular, metabolic, hepatic, immune, and brain function [6] [7] [8] . These ubiquitous actions of testosterone are 24 mediated by the androgen receptor (AR), encoded by the AR gene on the X chromosome, which is widely 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted  https://doi.org/10.1101/2022.02. 16 .21265846 doi: medRxiv preprint expressed in the testes, prostate, bone, skeletal muscle, heart, vascular smooth muscle, kidney, pulmonary 1 epithelial cells, bone marrow hematopoietic and immune cells, adipose tissue, and the central nervous system 2,9 . 2 Beginning in midlife men experience a progressive reduction in testicular androgen steroidogenesis, which 3 results in a roughly 1-3% decline in circulating levels of total testosterone per year 1,2,10,11 . Many men develop an 4 age-related testosterone deficiency or hypogonadism, which contributes to sexual dysfunction, frailty, sarcopenia, 5 coronary artery disease, metabolic syndrome and type 2 diabetes 1,2,10-12 . Testosterone levels in the hypogonadal 6 range have been reported to increase the risk of prostate cancer and predict recurrence after prostatectomy and 7 poor outcome in metastatic prostate cancer 13 . Testosterone deficiency has additionally been linked to depression, 8 neurodegeneration, cognitive impairment, and Alzheimer's disease risk during male aging [14] [15] [16] [17] [18] . To date, the 9 genetic factors that contribute to individual differences in circulating testosterone levels in men during aging 10 remain poorly understood. Furthermore, analysis of ancestry-specific genetic determinants governing testosterone 11 regulation has not been studied. 12 Total testosterone levels are heritable (~20%) and a number of genome-wide association studies (GWAS) 13 of testosterone levels have been conducted, identifying strong associations with SHBG, JMJD1C, FKBP4, 14 REEP3, and FAM9B [19] [20] [21] [22] [23] [24] [25] . However, most GWAS studies have been conducted primarily in European or Asian 15 ancestry groups whereas differences in testosterone levels have been observed in men of other ancestries 26-28 . In 16 this study, we conducted a GWAS of endogenous total testosterone levels in men enrolled in the Million Veteran 17 Program (MVP), a large, multi-ethnic genetic biorepository from a hospital-based population. As a hospital-based 18 population, MVP has higher disease prevalence of type 2 diabetes, obesity, hyperlipidemia, sleep apnea, gout, 19 prostate cancer, and testicular dysfunction/hypofunction compared to other population studies and offers unique 20 insights into testosterone regulation in a clinical setting. We identified 17 ancestry-specific testosterone gene 21 variants and 46 trans-ancestry testosterone gene variants, of which 15 ancestry-specific variants and 14 trans- 22 ancestry variants were novel. Colocalization and transcriptome-wide association study (TWAS) analysis revealed 23 novel cell-type specific associations between BRI3 and BAIAP2L1. Finally, we conducted phenome (PheWAS) 24 and laboratory value association studies (LabWAS), which revealed shared associations of testosterone with type 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted  https://doi.org/10.1101/2022.02. 16 .21265846 doi: medRxiv preprint 4 2 diabetes, hyperlipidemia, gout and liver disease and ancestry-specific association with diabetes in the African 1 ancestry group and hemolytic conditions in the Hispanic ancestry group. With this study, we gain insight into 2 ancestry-specific regulation of testosterone, highlighting the importance of conducting future studies in diverse 3 ancestry groups. 

Genome-wide analysis of Testosterone Levels 7 After phenotyping quality control, morning total testosterone levels were available for 145,576 male MVP 8 participants ( Figure S1 ). MVP participants were categorized using Harmonized Ancestry and Race/Ethnicity 9 (HARE), an algorithm which uses both self-reported and genetic ancestry to assign individuals to ancestry 10 groups 29 (Table 1) . Genome-wide association studies (GWAS) with testosterone levels were conducted separately 11 in European (n=88,385), African (n=25,235) and Hispanic (n=10,973) ancestry groups. Incorporating all genetic 12 information, we first assessed the heritability of testosterone levels from autosomal chromosomes across ancestry 13 groups using LD score regression 30 . Total testosterone levels showed the highest heritability in the African 14 ancestry group (h2=0.095) with significant GWAS hits (p<5e-08) accounting for 3.3% of heritability. Heritability 15 of total testosterone levels in the European and Hispanic ancestry groups were 0.071 and 0.084 with significant 16 hits (p<5e-08) accounting for 14.6% and 11.1% of heritability respectively (Table S1 ). Variants passing the 17 suggestive threshold (p<1e-05) explained 24.6%, 9.1%, 30.4% of heritability in European, African, and Hispanic 18 ancestry groups, respectively. 19 GWAS analyses identified 63 significant (p<5e-08) variants associated with testosterone across ancestry 20 groups: 30 significant autosomal loci for the European ancestry group, 5 for the African ancestry group and 3 for 21 the Hispanic ancestry group (Figure 1) . Several X chromosome variants remained significant after linkage-based 22 clumping. To identify independent loci, we conducted a conditional analysis, where we used the most significant 23 variants as covariates in the GWAS. Conditional analysis identified 9, 10 and 6 associations in European, African 24 and Hispanic cohorts, respectively (Figure 2A) . Variants near FAM9B, AR, RGAG1 were shared amongst all 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ancestry groups. X chromosome variant near DMD was identified specifically in the African ancestry group 1 ( Figure 2B ). DMD is responsible for dystrophin protein production and is mainly expressed in skeletal and 2 cardiac muscle, although some expression in the brain has been observed 31-34 . A Hispanic ancestry group-specific 3 variant near the ribosomal pseudogene RPS29P28 was also identified ( Figure 2C ). 4 Loci on chromosomes 10 and 17 were shared across different ancestry groups. Most unique peaks were 5 observed for the European ancestry group which had the largest sample size; however, unique peaks on 6 chromosomes 3, 7, 8 and X were observed in the African ancestry group. We compared beta coefficients of SNP 7 associations to determine if effects on testosterone were different amongst ancestry groups. Of the 63 variants, 10 8 variants had different effects on testosterone levels in the African ancestry group compared to the European 9 ancestry group. Four of these variants were located on the X chromosome, with other variants located on ancestry group compared to the European ancestry group. Three of these variants were located on chromosome 12 X, while the others were located on chromosomes 3, 7, 8, and 16. The chromosome 17 variant, rs980068134, was 13 identified as a trans-ancestry variant and was associated with lower testosterone levels in African and Hispanic 14 ancestry groups, but higher testosterone levels in the European ancestry group. 15 To validate the GWAS significant variants, we performed replication analyses for the European ancestry 16 group variants in the UK Biobank. Of the 39 European ancestry group variants, 31 passed a significance threshold 17 of 5e-08 in the UK Biobank (n=166,502) ( Figure S2A ). Of the remaining 8 which did not pass GWAS 18 significance threshold, 5 passed a significance threshold of 0.05. Comparable cohorts for the African and Hispanic 19 ancestry group powered for replication were unavailable. However, we obtained total testosterone levels for (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. African and Hispanic HARE groups used for testosterone GWAS. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 6 and the red line indicates the genome-wide significance threshold (5e-08). The innermost purple band corresponds 7 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. to measures of heterogeneity between ancestry group GWAS using Cochran's Q test. Second innermost ring 1 represents significant variants: red represents trans-ancestry variants, green represents Hispanic-specific variants, 2 blue represents African-specific variants and orange represents European-specific variants. Selected genes near 3 testosterone loci are indicated on the outside edge. A complete list of associations and nearby genes can be found 4 in Supplemental Table 1 . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. To evaluate the extent to which variants modifying total testosterone levels are shared between ancestry 2 groups, we estimated genetic correlation between groups by LD score (LDSC) regression 35 . While there was 3 significant correlation between all groups, higher genetic correlation was observed between European and 3A). 7 We next conducted genetic correlation analysis between our total testosterone GWAS results and 8 diseases/traits profiled in previous published GWASs using LDhub 36 , assessing differences in ancestry groups. 9 Significant positive correlation with HDL and lung function, including forced vital capacity (FVC) and forced 10 expiratory volume (FEV), were observed in European ancestry group (FDR < 0.1). Total testosterone levels were 11 significantly negatively correlated with obesity, BMI, Type 2 Diabetes, triglycerides and VLDL (FDR < 0.1) in 12 the European ancestry group. (Figure 3B ). No genetic correlations were significant in African and Hispanic 13 ancestry groups; however, genetic correlations were highly concordant amongst ancestry groups ( Figure S3A ). 14 Positive correlations between testosterone and glucose were observed in the Hispanic ancestry group, but not 15 European and African ancestry groups ( Figure S3B ). These findings suggest potential differences in testosterone 16 regulation of glucose between ancestry groups.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In order to identify candidate genes influencing testosterone levels we conducted a colocalization and a 2 transcriptome-wide association study (TWAS) using GTEx gene expression information. The colocalization 3 analysis estimates the probability of shared signal between cis-eQTL and GWAS analysis of testosterone 37 . Using 4 a probability of colocalization > 0.8, we identified 28 genes modulating testosterone levels (Figure 4) . Tissue 5 types with most identified genes included the thyroid (8) and aorta (6) . Additionally, genes were identified in 6 organs relevant to testosterone synthesis, such as the testis (3), prostate (2), liver (2) and adrenal gland (2). The 7 colocalization analysis revealed high colocalization between testosterone variants and cis variants for SHBG, 8 TNFSF12, BRI3, LAT, NRBF2, and BAIAP2L1. SHBG variants have been strongly associated with variation in 9 testosterone action 38,39 . BAIAP2L1 colocalization was specific to testes while BRI3 colocalization was specific to 10 the liver. Colocalization of LAT and TNFSF12 was specific for the brain putamen/basal ganglia and brain spinal 11 cord-cervical C1. 12 The TWAS implicated 214 genes and 22 tissue types in total testosterone regulation. Tissue types for 13 which most TWAS associations were identified included skin (sun-exposed), thyroid and tibial artery, consistent 14 with tissue types identified through colocalization analysis. Forty-six associations with Testis and 27 associations 15 with the Liver were observed. Of 28 genes identified by colocalization analysis, 23 were also identified by TWAS 16 analysis. BRI3 and BAIAP2L1, which are both located at chromosome 7, were identified specifically through liver 17 and testis TWAS analysis, specifically. BAIAP2L1 (Brain-Specific Angiogenesis Inhibitor 1-Associated Protein 18 2-Like Protein 1) is expressed in urothelial and glandular cells and has been implicated in previous GWAS studies 19 of testosterone 40 . Gene expression studies identified BAIAP2L1 to be upregulated with age and downregulated 20 with riluzole treatment, a glutamate modulator shown to improve memory function in aged rats 41 . BRI3, or Brain 21 protein I3, is a negative regulator of amyloid precursor protein (APP) 42 , providing a further link between the 22 genetic determinants of testosterone regulation and Alzheimer's disease pathophysiology. Although these genes 23 have been implicated through tissues such as liver and testes, they might have broad effects on the human body 24 and oncogenic mechanisms 43-45 . 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. To determine ancestry-associated differences in genetic regulation of testosterone, we conducted a 1 Network Assisted Genomic Association (NAGA) on the GWAS results from each ancestry group and compared 2 the top 50 implicated genes. Twenty-five genes were shared across all groups, including SHBG, TNFSF12, 3 SENP3, JMJD1C, RRAG1, and TP53. Unique genes for the African ancestry group included MSN, DMD, 4 GAGE2B and GAGE2C, while unique genes for the Hispanic ancestry group included SERPINA7, TKTL1, 5 TTC28, and PNPLA3. Of the genes uniquely implicated, 9 and 2 were on chromosome X for African and Hispanic 6 ancestry groups, respectively. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 6 and 7, respectively. 8 9 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 9 Given the availability of extensive electronic health record data in the MVP, we conducted a phenome- 10 wide association study (PheWAS) among individual level genotypes and ICD-10 code data to determine whether 11 the 46 trans-ancestry testosterone variants were associated with disease risk. We identified 920, 45 and 56 12 significant associations (FDR < .01) in the European, African and Hispanic ancestry groups, respectively. Nine 13 variants had PheWAS associations across all ancestry groups; 2 had associations uniquely in the African ancestry 14 group. Across all ancestry groups, PheWAS associations for testicular dysfunction/hypofunction, 15 hyperglyceridemia, gout, type 2 diabetes, chronic liver disease, hepatomegaly and hyperlipidemia were observed 16 ( Figure 6A ). In general, testosterone-increasing variants across ancestry groups were associated with lower odds 17 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.21265846 doi: medRxiv preprint of testicular hypofunction, dysfunction, morbid obesity, hyperglyceridemia, sleep apnea, diabetes mellitus, gout, 1 hyperlipidemia and increased odds of hepatomegaly, liver disease and esophageal bleeding. Opposite to general 2 trends, two variants on chromosome 2 and 17 (rs1260326, rs188272638) in GCKR and POLR2A, respectively, in 3 the European ancestry group were associated with increased testosterone and increased obesity. Trans-ancestry 4 variant rs190119169, an AR variant on chromosome X, was associated with increased testosterone across all 5 ancestry groups (beta_eur=4.85, beta_afr=7.87, beta_his=6.11), but only significantly associated with lower odds 6 of diabetes in the African ancestry group ( Figure 6B) . Two testosterone-increasing variants, rs112635299 on Since testosterone can influence lab measurements 46 , we also ran LabWAS associations with 46 trans-11 ancestry variants and mean levels of lipid, metabolic and blood lab values. We identified 668 significant 12 associations in the European, 150 in the African and 44 in the Hispanic ancestry groups (FDR<.01). Across all 13 ancestry groups, significant associations with calcium, aspartate aminotransferase (AST), bicarbonate, A1c, 14 hematocrit, estimated glomerular filtration rate (eGFR), alanine aminotransferase (ALT), HDL-C, iron, glucose, 15 albumin, hemoglobin, LDL-C, international normalized ratio (INR), creatinine and chloride were observed. Of 16 these shared associations, most associations with HDL-C, albumin and LDL-C were observed in the European 17 ancestry group compared to glucose, hemoglobin and LDL-C in the African ancestry group. rs190119169, which 18 was significantly associated with lower odds of diabetes in the African ancestry group, was also associated with 19 significantly lower levels of mean glucose levels (beta=-5.14) in contrast to the European (beta=-0.60) and 20 Hispanic (beta=-3.32) ancestry groups ( Figure 7A ). 21 We next evaluated PheWAS and LabWAS associations of 17 ancestry-specific variants. One of the 8 22 African-ancestry specific variants and 3 of the 5 Hispanic ancestry-specific variants had PheWAS association in 23 respective ancestry groups. African-specific ancestry variant rs4827451 on chromosome X was uniquely 24 associated with diabetes, diabetic retinopathy and renal failure in the African ancestry group. This variant was 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.21265846 doi: medRxiv preprint also uniquely associated with A1c, glucose and eGFR in the African ancestry group ( Figure 7B) . One of the 1 genes in close proximity to rs4827451 is MSN, which could have potential mechanisms in renal fibrosis. 2 rs73629199, a TKTL1 variant on chromosome X, was uniquely associated with hereditary hemolytic anemias in 3 the Hispanic ancestry group. Furthermore, significant associations were observed with hematocrit, ferritin, 4 hemoglobin in the Hispanic ancestry group along with the African ancestry group.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Given the numerous PheWAS and LabWAS associations with testosterone variants, we wanted to assess 6 the predictive value of testosterone variants for different clinical phenotypes. We constructed a testosterone 7 polygenic score from 46 trans-ancestry variants, which we validated in the MVP cohort ( Figure 7C ) and the UK 8 Biobank (Figure S4) . Distribution of testosterone polygenic scores amongst ancestry groups were significantly 9 different (t-test p < 2e-16). The African ancestry group had the highest average testosterone PGS scores 10 (mean=7.76, std=0.26) followed by the European (mean=5.88,std=0.34) and Hispanic ancestry groups 11 (mean=4.69, std=0.40) ( Figure S5 ). 12 To assess the predictive value of the testosterone PGS for clinical phenotypes, we conducted association Hispanics as compared to the European and African ancestry groups. Furthermore, testosterone PGS was uniquely 21 associated with lower odds of prostate cancer in the Hispanic and African ancestry groups, but not European 22 ancestry group. These results suggest a differential role for testosterone regulation in disease risk stratification 23 across ancestry groups. 24 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.21265846 doi: medRxiv preprint testosterone PGS association with testicular dysfunction, testicular hypofunction, hyperlipidemia, gout, type 1 1 and 2 diabetes, and prostate cancer. Utilizing data from the MVP cohort, we present the largest multi-ancestral genome-wide analysis of total 5 testosterone levels to our knowledge. We identified 46 trans-ancestry variants of which 14 were novel. We It is well-established that testosterone is immunosuppressive dampening many aspects of humoral-and infection, and other diseases 55, 56 . Identification of immunomodulatory genes specifically in the African ancestry 22 group suggests an ancestry-specific genetic link between testosterone and the immune system that is important to 23 explore.

24 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Our analysis found novel European ancestry-specific variants for the Ephrin B1 (EFNB1) gene at Xq13 1 and the WW Domain Containing Oxidoreductase (WWOX) gene at 16q23.1-2 that were associated with 2 testosterone levels. The EFNB1 gene encodes a ligand for Ephrin receptor tyrosine kinases, which has critical 3 roles in migration and adhesion of brain neurons and cells in the lung, adipose tissue, kidney, and cardiovascular 4 system during development. Recently, EFNB1 in hippocampal astrocytes has been found to regulate excitatory 5 and inhibitory neurocircuits and exert a neuroprotective role in the adult brain 57,58 . The WWOX protein contains 6 a short-chain dehydrogenase reductase (SDR) domain at its C-terminus that is involved in androgen 7 steroidogenesis in Leydig cells of the testis; knockout of the WWOX results in a severe testosterone deficiency, 8 impaired hematopoiesis and cholesterol metabolism, and renal failure 59 . Furthermore, a recent genetic meta-9 analysis discovered that the WWOX locus has a genome-wide association with Alzheimer's disease 60 . Low 10 testosterone levels in men is a risk factor for dementia 61 . Furthermore, testosterone replacement therapy (TRT) 11 can modestly improve cognition 62 , suggesting testosterone has a potential protective effect for dementia. Novel 12 testosterone loci in genetic regions relevant to dementia may be due to the higher representation of disease in the 13 MVP that are not available in other biobanks and highlight genetic links between testosterone and memory 14 function. 15 The SHBG locus on chromosome 17 was significantly associated with testosterone levels across ancestry 16 groups, however, differences in PheWAS associations at this locus were observed in the three ancestries. 17 rs918121801 was only associated with testicular dysfunction and hypofunction in the African ancestry group 18 while rs62059839, in close proximity to rs918121801, was associated with testicular dysfunction and 19 hypofunction in the European ancestry group. High heterogeneity at the SHBG locus was calculated amongst 20 ancestry groups and SHBG levels are known to be highly heritable [63] [64] [65] . Thus, differences in PheWAS associations 21 within the SHBG locus may reflect complex linkage disequilibrium patterns between ancestry groups 66 or a shared 22 causal variant with different ancestry group specific markers. Causality analysis and fine mapping of the SHBG 23 locus may help to better understand ancestry-specific differences in testosterone regulation. 24 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also linked ancestry-specific variants with differential disease risk in African and Hispanic ancestry 1 groups. Specifically, chromosome X variant rs4827451 was associated with lower testosterone levels and eGFR 2 and higher odds of chronic kidney disease and renal failure. Hypogonadism is frequently observed in renal 3 failure 67 , increasing risk of anemia and cardiovascular disease. Furthermore, sex-specific and ancestry-specific group specifically. Furthermore, the variant is located in close proximity to MSN, which is involved in renal 10 fibrosis through E-cadherin interaction 70 . These findings demonstrate a potential ancestry-specific genetic 11 mechanism in the kidney that requires further investigation. 12 A unique PheWAS association between a TKTL1 variant and hereditary hemolytic anemias was identified 13 in the Hispanic ancestry group. Lower testosterone levels are associated with higher rates of anemia in men, while 14 testosterone replacement therapy stimulates iron-dependent erythropoiesis and has beneficial effects on anemia. 15 Given the high heritability of red blood cell (RBC) traits 71 , the identified TKTL1 variant may give insight into 16 androgen-related genetic regulation of anemia in non-European individuals. Furthermore, rs73629199 was 17 associated with RBC-related lab values such as ferritin, hematocrit, and hemoglobin that links testosterone with 18 RBC regulation. 19 Of the 17 ancestry-specific variants, 8 were identified in the African, 5 were identified in Hispanic, and 4 20 were identified in European ancestry group analyses. Most African ancestry-specific variants were found on 21 chromosome X, however, we discovered LIN01414 was a unique variant on chromosome 8. Based on LD score 22 regression analysis, heritability of testosterone levels were highest in the African ancestry group; however, 23 significant variants only explain a minority of heritability (3.3%). Even using a suggestive threshold, heritability 24 explained was 9.1% compared to 24.6% and 30.4% in European and Hispanic ancestry groups, respectively. 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Differences in total testosterone levels have been observed in African individuals and several of the diseases 1 implicated by PheWAS analysis of testosterone levels, such as diabetes, cardiovascular disease, and chronic renal 2 disease, occur at higher rates in individuals of African ancestry 72-81 . Understanding androgen-related regulation 3 of diseases in individuals of African ancestry is critical and will require larger sample sizes. 4 We constructed a polygenic score (PGS) for testosterone using 46 trans-ancestry variants and observed 5 differential associations with gout and diabetes in the Hispanic ancestry group compared to European and African 6 ancestry groups. Furthermore, PGS was associated with lower odds of prostate cancer in the Hispanic and African 7 ancestry groups compared to the European ancestry group. In hyperlipidemia and testicular dysfunction, PGS 8 associations were more concordant across ancestry groups. These findings highlight shared effects of testosterone 9 on disease risk, but also reveal differences that give insight into ancestry group-specific genetic architecture of 10 testosterone.

The Million Veteran Program provides a breadth of clinical and genomic data that has allowed us to 12 conduct the most ancestrally diverse genetic analysis of total testosterone levels to date. We note limitations with 13 exploring ancestry group-specific mechanisms as the tissue-specific gene expression data that are available come 14 predominantly from individuals with European ancestry. Thus, our TWAS and colocalization analysis rely on 15 European gene expression data; however, gene expression patterns may be influenced by ancestry group 16 differences. Furthermore, our PheWAS analysis focused on ICD10 codes for clinical phenotyping. These clinical 17 outcomes are important for assessing disease risk; however, testosterone can also impact disease severity, In summary, we conducted a large-scale multi-ancestry GWAS of morning total testosterone levels in men 22 from the Million Veteran Program and discovered multiple novel trans-ancestry and ancestry-specific variants 23 influencing testosterone levels. Using additional clinical and gene expression data, we linked ancestry-group 24 germline variant differences with differential disease risk and constructed a polygenic risk score predictive of a 25 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 17, 2022. ; https://doi.org/10.1101/2022.02.16.21265846 doi: medRxiv preprint variety of clinical phenotypes. These results provide unique insights into not only testosterone regulation but also 1 ancestry group differences in genetic regulation of testosterone. androgen deprivation therapy (ADT), and testosterone replacement therapy (TRT) were excluded from analysis 12 to focus on analysis of endogenous testosterone levels. In patients with multiple testosterone levels readings, first 13 testosterone reading was used.

14 For European ancestral group testosterone loci validation, field ID 30850 (Testosterone nmol/L) was 15 extracted and inverse-rank normalized from UK Biobank. PLINK 82 glm method was used to calculate beta and 16 p-values for variants identified in MVP discovery analysis. UK Biobank validation cohort consisted of 166,502 17 European, unrelated men. Top 10 principal components (PC1-PC10) and age were used as covariates.

For African ancestral group testosterone loci validation, total testosterone values were extracted and (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. PLINKv2.0 glm method was used to run stepwise conditional analysis for identification of independent X 1 chromosome associations 83 . First, association with testosterone was conducted and SNP with lowest p-value was 2 identified. Next association with testosterone was run conditioning on most significant variants. Analysis was 3 conducted until no SNPs with p-value < 1x10 -6 remained. To reduce the chance of multicollinearity, variants 4 which were within 50kb of the most recent significant variant were excluded from the selection process. Genomes EUR, AFR, and AMR groups, respectively. For partitioned heritability analysis, categories for analysis 9 included base and significant category for variants which based p-value threshold (p < 5e-08) for each ancestral 10 group 84 . Genetic correlation analysis was conducted with summary statistics for each ancestral group using LD 11 scores from both groups in analysis 35 . Lastly, for LD hub analysis, summary statistics were uploaded to LD Hub 12 server (http://ldsc.broadinstitute.org/). Genetic correlations in UK Biobanks and "reproductive" category were 13 excluded. FDR was calculated from LD hub provided p-values. 14 15 Colocalization Analysis 16 Significant variants (p < 5e-08) for each ancestral group were compared with significant GTEx eQTL results 17 (accession date: 10/02/2019). All genes for which significant eQTL association was shared were included in 18 colocalization analysis. Full summary statistics for GTEx cis-eQTL analysis were used to make input files 19 including samples sizes and p-values for both GTEx and MVP testosterone summary statistics from European 20 ancestral group. Minor allele frequency from GTEx consortium was included for final coloc analysis. coloc.abf (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. incidence of phecode. Covariates included age at testosterone lab and first 10 genetic principal components. 10 Mean lab values for 68 measurements were available. As was done for the PheWAS, associations with 11 mean lab values were conducted with PLINK using top 10 principal components and age as covariates. 12 False discovery rates (FDR) for PheWAS and LabWAS associations were calculated using Hochberg correction 86 with python statsmodel package 87 . Associations with FDR less than 1% were considered 14 significant. 15 16 Testosterone Polygenic Score (PGS) 17 Meta-analysis of European, African and Hispanic testosterone GWAS were conducted with METAL. Variants (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 8 For LDhub analysis, we gratefully acknowledge all the studies and databases that made GWAS summary (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The full summary-level association data from this report are available upon request. Source data are provided 12 with this paper.

Code Availability 15 Code to reproduce manuscript figures is available at: https://github.com/meghanasp21/mvp-testosterone-gwas 16 17 Competing Interests 18 Authors do not report any conflicts of interest. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The Endocrine Control of Male Phenotypic

Androgens and erythropoiesis: past and present

Testosterone action on skeletal muscle. Current Opinion in Clinical Nutrition 6 and Metabolic Care

Testosterone: a vascular hormone in health and disease

Understanding androgen action in adipose tissue

Androgen Receptor Structure, Function and Biology: From Bench to 14

The decline of androgen levels in elderly men and its clinical and 16 therapeutic implications

Aging and the Male 18 Reproductive System

Male late-onset hypogonadism: pathogenesis, diagnosis and treatment

Prevalence of prostate cancer among hypogonadal men with prostate-22 specific antigen levels of 4.0 ng/mL or less

Androgens and depression: a review and update

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Testosterone modifies the effect of APOE genotype on hippocampal volume in 1 middle-aged men

The Role of Sex and Sex Hormones in Neurodegenerative Diseases

Gender, sex steroid hormones, and Alzheimer's disease

Hormonal changes and their impact on cognition and mental health of ageing men

Using human genetics to understand the disease impacts of testosterone in men and 9 women

GWAS of three molecular traits highlights 11 core genes and pathways alongside a highly polygenic background

Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal 13 Study reveals novel associations

Sex-specific genetic effects across biomarkers

Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence 16 serum androgen levels in men

Genetic determinants of serum testosterone concentrations in men

Genome-wide association study of sex hormones, gonadotropins and sex hormone-binding 20 protein in Chinese men

A genome-wide association meta-analysis of circulating sex hormone-binding 1 globulin reveals multiple Loci implicated in sex steroid hormone regulation

Age and Alzheimer's disease gene expression profiles reversed by the glutamate 4 modulator riluzole

BRI3 inhibits amyloid precursor protein processing in a 6 mechanistically distinct manner from its homologue dementia gene BRI2

The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in

Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-11 BAIAP2L1

Nifedipine promotes the proliferation and migration of 13 breast cancer cells

Effects of testosterone replacement on glucose and lipid 15 metabolism

VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages

CRIg: a macrophage complement receptor required for phagocytosis of circulating 19 pathogens

VSIG4, a B7 family-related protein, is a negative regulator of T cell activation

(ezrin/radixin/moesin) family: from cytoskeleton to signal transduction

ERM proteins and merlin: integrators at the cell cortex. Nature 25 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The ERM protein Moesin is essential for neuronal morphogenesis and 2 long-term memory in Drosophila

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing 4 immune lymphocyte infiltration

Testosterone promotes vascular endothelial cell migration 6 via upregulation of ROCK-2/moesin cascade

Testosterone as a protective factor 8 against atherosclerosis--immunomodulation and influence upon plaque development and stability

Testosterone Deficiency Is a Risk Factor for Severe COVID-19

Presenilin1 familial Alzheimer disease mutants inactivate EFNB1-and BDNF-13 dependent neuroprotection against excitotoxicity by affecting neuroprotective complexes of N-methyl-d-14 aspartate receptor

Astrocytic Ephrin-B1 Controls Excitatory-Inhibitory Balance in Developing 16

Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor 18 leads to impaired steroidogenesis

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and 20 implicates Aβ, tau, immunity and lipid processing

Low testosterone and the risk of dementia in elderly men: Impact of age and education

The Effects of Testosterone Supplementation on Cognitive Functioning in 24

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Quantitative genetics of serum 1 sex hormone-binding globulin levels in participants in the

Heritability of plasma sex hormones and hormone binding globulin in adult male twins

Heritability of blood concentrations of sex-steroids in relation to body composition in 6 young adult male siblings

Linkage disequilibrium patterns of the human genome across populations

Prevalence and clinical implications of testosterone deficiency in men with end-stage 10 renal disease

Hypogonadism and testosterone replacement therapy in end-stage renal 12 disease (ESRD) and transplant patients

The role of testosterone in chronic kidney disease and kidney function in 14 men and women: a bi-directional Mendelian randomization study in the UK Biobank

Role of moesin in renal fibrosis

Genome-wide association study of red blood cell traits in Hispanics/Latinos: The 18

Hispanic Community Health Study/Study of Latinos

Cardiovascular Health in African Americans: A Scientific Statement From the 20

Diabetes in African Americans

Kidney Disease Among African Americans: A Population 23 Perspective

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Race, gender, and socioeconomic disparities in CKD in the United States

Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in

The Third National Health and Nutrition Examination Survey

Vital Statistics

Racial/Ethnic Disparities in Quality of Care for 11

PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage

Conditional analysis identifies three novel major histocompatibility complex loci 17 associated with psoriasis

Partitioning heritability by functional annotation using genome-wide association 19 summary statistics

Integrative approaches for large-scale transcriptome-wide association studies

Controlling the False Discovery Rate: A Practical and Powerful Approach 23 to Multiple Testing

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.